Adverse Reactions to Tremelimumab, Durvalumab in Liver Cancer
In recent years, the advent of immune checkpoint inhibitors has revolutionized the therapeutic landscape of hepatocellular carcinoma (HCC), a primary ...
In recent years, the advent of immune checkpoint inhibitors has revolutionized the therapeutic landscape of hepatocellular carcinoma (HCC), a primary ...
In the evolving landscape of pediatric medicine, understanding the safety profiles of commonly prescribed antibiotics remains pivotal. A recent groundbreaking ...
In recent years, chimeric antigen receptor T-cell therapy, commonly known as CAR-T therapy, has revolutionized the field of oncology, offering ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine